-
1دورية أكاديمية
المؤلفون: Yu-Chen Cheng, Shayna Stein, Agostina Nardone, Weihan Liu, Wen Ma, Gabriella Cohen, Cristina Guarducci, Thomas O. McDonald, Rinath Jeselsohn, Franziska Michor
مصطلحات موضوعية: Cancer, Tumor Biology, Molecular and Cellular Biology, Therapeutic Research and Development, Methods and Technology, Computational Methods, Mathematical modeling, Tumor Evolution, Breast Cancer, Small Molecule Agents, Endocrinology, Hormone signaling and inhibitors, Cell Cycle, CDKs and CDK inhibitors
الإتاحة: https://doi.org/10.1158/2767-9764.24574045.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Table_S3_from_Mathematical_Modeling_Identifies_Optimum_Palbociclib-fulvestrant_Dose_Administration_Schedules_for_the_Treatment_of_Patients_with_Estrogen_Receptor_positive_Breast_Cancer/24574045Test -
2دورية أكاديمية
المؤلفون: Yu-Chen Cheng, Shayna Stein, Agostina Nardone, Weihan Liu, Wen Ma, Gabriella Cohen, Cristina Guarducci, Thomas O. McDonald, Rinath Jeselsohn, Franziska Michor
مصطلحات موضوعية: Cancer, Tumor Biology, Molecular and Cellular Biology, Therapeutic Research and Development, Methods and Technology, Computational Methods, Mathematical modeling, Tumor Evolution, Breast Cancer, Small Molecule Agents, Endocrinology, Hormone signaling and inhibitors, Cell Cycle, CDKs and CDK inhibitors
الإتاحة: https://doi.org/10.1158/2767-9764.24574048.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Table_S2_from_Mathematical_Modeling_Identifies_Optimum_Palbociclib-fulvestrant_Dose_Administration_Schedules_for_the_Treatment_of_Patients_with_Estrogen_Receptor_positive_Breast_Cancer/24574048Test -
3دورية أكاديمية
المؤلفون: Yu-Chen Cheng, Shayna Stein, Agostina Nardone, Weihan Liu, Wen Ma, Gabriella Cohen, Cristina Guarducci, Thomas O. McDonald, Rinath Jeselsohn, Franziska Michor
مصطلحات موضوعية: Cancer, Tumor Biology, Molecular and Cellular Biology, Therapeutic Research and Development, Methods and Technology, Computational Methods, Mathematical modeling, Tumor Evolution, Breast Cancer, Small Molecule Agents, Endocrinology, Hormone signaling and inhibitors, Cell Cycle, CDKs and CDK inhibitors
الإتاحة: https://doi.org/10.1158/2767-9764.24574069.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Fig_S4_from_Mathematical_Modeling_Identifies_Optimum_Palbociclib-fulvestrant_Dose_Administration_Schedules_for_the_Treatment_of_Patients_with_Estrogen_Receptor_positive_Breast_Cancer/24574069Test -
4دورية أكاديمية
المؤلفون: Yu-Chen Cheng, Shayna Stein, Agostina Nardone, Weihan Liu, Wen Ma, Gabriella Cohen, Cristina Guarducci, Thomas O. McDonald, Rinath Jeselsohn, Franziska Michor
مصطلحات موضوعية: Cancer, Tumor Biology, Molecular and Cellular Biology, Therapeutic Research and Development, Methods and Technology, Computational Methods, Mathematical modeling, Tumor Evolution, Breast Cancer, Small Molecule Agents, Endocrinology, Hormone signaling and inhibitors, Cell Cycle, CDKs and CDK inhibitors
الإتاحة: https://doi.org/10.1158/2767-9764.24574051.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Table_S1_from_Mathematical_Modeling_Identifies_Optimum_Palbociclib-fulvestrant_Dose_Administration_Schedules_for_the_Treatment_of_Patients_with_Estrogen_Receptor_positive_Breast_Cancer/24574051Test -
5دورية أكاديمية
المؤلفون: Yu-Chen Cheng, Shayna Stein, Agostina Nardone, Weihan Liu, Wen Ma, Gabriella Cohen, Cristina Guarducci, Thomas O. McDonald, Rinath Jeselsohn, Franziska Michor
مصطلحات موضوعية: Cancer, Tumor Biology, Molecular and Cellular Biology, Therapeutic Research and Development, Methods and Technology, Computational Methods, Mathematical modeling, Tumor Evolution, Breast Cancer, Small Molecule Agents, Endocrinology, Hormone signaling and inhibitors, Cell Cycle, CDKs and CDK inhibitors
الإتاحة: https://doi.org/10.1158/2767-9764.24574066.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Fig_S5_from_Mathematical_Modeling_Identifies_Optimum_Palbociclib-fulvestrant_Dose_Administration_Schedules_for_the_Treatment_of_Patients_with_Estrogen_Receptor_positive_Breast_Cancer/24574066Test -
6دورية أكاديمية
المؤلفون: Yu-Chen Cheng, Shayna Stein, Agostina Nardone, Weihan Liu, Wen Ma, Gabriella Cohen, Cristina Guarducci, Thomas O. McDonald, Rinath Jeselsohn, Franziska Michor
مصطلحات موضوعية: Cancer, Tumor Biology, Molecular and Cellular Biology, Therapeutic Research and Development, Methods and Technology, Computational Methods, Mathematical modeling, Tumor Evolution, Breast Cancer, Small Molecule Agents, Endocrinology, Hormone signaling and inhibitors, Cell Cycle, CDKs and CDK inhibitors
الإتاحة: https://doi.org/10.1158/2767-9764.24574054.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Fig_S9_from_Mathematical_Modeling_Identifies_Optimum_Palbociclib-fulvestrant_Dose_Administration_Schedules_for_the_Treatment_of_Patients_with_Estrogen_Receptor_positive_Breast_Cancer/24574054Test -
7دورية أكاديمية
المؤلفون: Yu-Chen Cheng, Shayna Stein, Agostina Nardone, Weihan Liu, Wen Ma, Gabriella Cohen, Cristina Guarducci, Thomas O. McDonald, Rinath Jeselsohn, Franziska Michor
مصطلحات موضوعية: Cancer, Tumor Biology, Molecular and Cellular Biology, Therapeutic Research and Development, Methods and Technology, Computational Methods, Mathematical modeling, Tumor Evolution, Breast Cancer, Small Molecule Agents, Endocrinology, Hormone signaling and inhibitors, Cell Cycle, CDKs and CDK inhibitors
الإتاحة: https://doi.org/10.1158/2767-9764.24574057.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Fig_S8_from_Mathematical_Modeling_Identifies_Optimum_Palbociclib-fulvestrant_Dose_Administration_Schedules_for_the_Treatment_of_Patients_with_Estrogen_Receptor_positive_Breast_Cancer/24574057Test -
8دورية أكاديمية
المؤلفون: Yu-Chen Cheng, Shayna Stein, Agostina Nardone, Weihan Liu, Wen Ma, Gabriella Cohen, Cristina Guarducci, Thomas O. McDonald, Rinath Jeselsohn, Franziska Michor
مصطلحات موضوعية: Cancer, Tumor Biology, Molecular and Cellular Biology, Therapeutic Research and Development, Methods and Technology, Computational Methods, Mathematical modeling, Tumor Evolution, Breast Cancer, Small Molecule Agents, Endocrinology, Hormone signaling and inhibitors, Cell Cycle, CDKs and CDK inhibitors
الإتاحة: https://doi.org/10.1158/2767-9764.24574060.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Fig_S7_from_Mathematical_Modeling_Identifies_Optimum_Palbociclib-fulvestrant_Dose_Administration_Schedules_for_the_Treatment_of_Patients_with_Estrogen_Receptor_positive_Breast_Cancer/24574060Test -
9دورية أكاديمية
المؤلفون: Yu-Chen Cheng, Shayna Stein, Agostina Nardone, Weihan Liu, Wen Ma, Gabriella Cohen, Cristina Guarducci, Thomas O. McDonald, Rinath Jeselsohn, Franziska Michor
مصطلحات موضوعية: Cancer, Tumor Biology, Molecular and Cellular Biology, Therapeutic Research and Development, Methods and Technology, Computational Methods, Mathematical modeling, Tumor Evolution, Breast Cancer, Small Molecule Agents, Endocrinology, Hormone signaling and inhibitors, Cell Cycle, CDKs and CDK inhibitors
الإتاحة: https://doi.org/10.1158/2767-9764.24574063.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Fig_S6_from_Mathematical_Modeling_Identifies_Optimum_Palbociclib-fulvestrant_Dose_Administration_Schedules_for_the_Treatment_of_Patients_with_Estrogen_Receptor_positive_Breast_Cancer/24574063Test -
10دورية أكاديمية
المؤلفون: Yu-Chen Cheng, Shayna Stein, Agostina Nardone, Weihan Liu, Wen Ma, Gabriella Cohen, Cristina Guarducci, Thomas O. McDonald, Rinath Jeselsohn, Franziska Michor
مصطلحات موضوعية: Cancer, Tumor Biology, Molecular and Cellular Biology, Therapeutic Research and Development, Methods and Technology, Computational Methods, Mathematical modeling, Tumor Evolution, Breast Cancer, Small Molecule Agents, Endocrinology, Hormone signaling and inhibitors, Cell Cycle, CDKs and CDK inhibitors
الإتاحة: https://doi.org/10.1158/2767-9764.24574072.v1Test
https://figshare.com/articles/journal_contribution/Supplementary_Fig_S3_from_Mathematical_Modeling_Identifies_Optimum_Palbociclib-fulvestrant_Dose_Administration_Schedules_for_the_Treatment_of_Patients_with_Estrogen_Receptor_positive_Breast_Cancer/24574072Test